ky1005
Showing 1 - 4 of 4
Immune System Diseases Trial in London (KY1005)
Completed
- Immune System Diseases
- KY1005
-
London, United KingdomHammersmith Medicines Research
Sep 29, 2021
Dermatitis, Atopic Trial in Worldwide (KY1005, Placebo)
Completed
- Dermatitis, Atopic
- KY1005
- Placebo
-
Kiel, Germany
- +18 more
Apr 30, 2021
Eczema, Atopic Dermatitis Trial in Worldwide (KY1005, Placebo)
Active, not recruiting
- Eczema
- Atopic Dermatitis
- KY1005
- Placebo
-
Fremont, California
- +102 more
Dec 13, 2022
Immune System Diseases Trial in Leiden (KY1005, Placebo)
Completed
- Immune System Diseases
- KY1005
- Placebo
-
Leiden, NetherlandsCentre for Human Drug Research
Aug 28, 2019